支气管镜肺泡灌洗液微生物检测技术在肺部 疾病诊断中的应用进展
Application Progress of Bronchoscopic Bronchoalveolar Lavage Fluid Microbiological Detection Technology in the Diagnosis of Pulmonary Diseases
摘要: 肺部疾病的病因向来复杂,临床上面临两个关键问题:一是感染与非感染性病变的鉴别,二是病原体的快速明确,这两点直接决定了治疗走向。支气管镜肺泡灌洗液(BALF)直接取自肺泡和小气道,能较好地避开上呼吸道菌群的干扰,反映下呼吸道的真实微生态和感染状况,因此在肺部疾病的病原学诊断中具有独特优势。过去,BALF的微生物检测主要依赖涂片和培养,但灵敏度低、耗时长、能检测的病原体种类有限。近年来,实时荧光定量PCR、数字PCR、宏基因组二代测序、靶向测序以及质谱技术等陆续进入临床,不仅明显提高了病原体检出率和诊断准确性,也在间质性肺疾病、肺癌等非感染性疾病的微生态研究中展现出潜力。本文就BALF微生物检测技术的发展、各类技术的特点、临床应用现状、存在的问题以及未来方向进行综述,希望能为临床精准诊疗提供一些参考。
Abstract: The etiologies of pulmonary diseases have always been complex. Clinically, there are two key challenges: the differentiation between infectious and non-infectious lesions, and the rapid identification of pathogens, both of which directly determine the treatment strategy. Bronchoalveolar lavage fluid (BALF) is directly collected from the alveoli and small airways, which can effectively avoid the interference of upper respiratory tract flora and reflect the real microecology and infectious status of the lower respiratory tract. Therefore, it possesses unique advantages in the etiological diagnosis of pulmonary diseases. In the past, the microbiological detection of BALF mainly relied on smear microscopy and microbial culture, which were limited by low sensitivity, long detection cycle and narrow coverage of detectable pathogens. In recent years, emerging technologies including real-time fluorescence quantitative PCR, digital PCR, metagenomic next-generation sequencing, targeted sequencing and mass spectrometry have been gradually applied in clinical practice. These techniques have significantly improved the pathogen detection rate and diagnostic accuracy, and also shown great potential in the microecological research of non-infectious pulmonary diseases such as interstitial lung disease and lung cancer. This article reviews the development of BALF microbiological detection technologies, the characteristics of various detection methods, current clinical application status, existing limitations and future research directions, so as to provide references for precise clinical diagnosis and treatment of pulmonary diseases.
文章引用:张琪, 白一帆, 安欢, 张利, 李元军. 支气管镜肺泡灌洗液微生物检测技术在肺部 疾病诊断中的应用进展[J]. 临床医学进展, 2026, 16(5): 3046-3054. https://doi.org/10.12677/acm.2026.1652119

参考文献

[1] 吴振华, 上官文静, 王传光, 等. 宏基因组下一代测序技术检测肺部感染病原体研究进展[J]. 中国病原生物学杂志, 2023, 18(7): 864-867.
[2] 刘珍珍, 刘谩, 贾永庆, 等. 宏基因组二代测序技术在肺部感染病原体检测中的应用价值[J]. 罕少疾病杂志, 2025, 32(7): 84-86.
[3] 刘钰, 孙小琴, 刘婷, 等. 宏基因组二代测序在肺部感染病原体检测中的临床应用[J]. 中华医院感染学杂志, 2025, 35(13): 1942-1947.
[4] 闵依. 靶向高通量测序和二代宏基因组测序在下呼吸道感染中诊断价值的临床研究[D]: [硕士学位论文]. 湛江: 广东医科大学, 2025.
[5] 呼吸道传染病标本采集及检测专家委员会. 呼吸道传染病标本采集及检测专家共识[J]. 中华实验和临床感染病杂志(电子版), 2022, 16(4): 217-228.
[6] 中华医学会呼吸病学分会. 肺部感染性疾病支气管肺泡灌洗病原体检测中国专家共识(2017年版) [J]. 中华结核和呼吸杂志, 2017, 40(8): 578-583.
[7] 赵莹, 赵瑞, 苗永帅, 等. tNGS技术在肺炎病原学诊断中的应用研究进展[J]. 诊断病理学杂志, 2026, 33(2): 283-286.
[8] 娜迪热·海如拉, 再乃甫·乃比江, 马志华, 等. 支气管肺泡灌洗液宏基因二代测序技术在重症肺炎患儿病原学检测中的应用价值[J]. 中国临床医生杂志, 2024, 52(9): 1096-1099.
[9] 李俏, 苏振中, 许璐璐, 等. 宏基因二代测序技术在肺部感染病原学检测中应用的研究进展[J]. 吉林大学学报(医学版), 2023, 49(5): 1382-1387.
[10] 邸红芹, 杨永辉, 康丽菲, 等. 多种呼吸道病原体的多重实时荧光定量PCR检测方法的建立及应用[J]. 河北医科大学学报, 2016, 37(11): 1302-1306.
[11] 中华医学会儿科学分会新生儿学组, 中华儿科杂志编辑委员会, 周文浩, 等. 宏基因组二代测序技术在新生儿感染性疾病中的临床应用专家共识[J]. 中华儿科杂志, 2022, 60(6): 516-521.
[12] 中国医学装备协会检验医学分会. 靶向二代测序在感染性疾病诊疗中的规范化应用专家共识2025 [J]. 中华检验医学杂志, 2025, 48(4): 469-477.
[13] 朱庆东, 宋畅, 黄爱春, 等. 支气管肺泡灌洗液纳米孔测序对肺结核的诊断价值[J]. 中国防痨杂志, 2025, 47(11): 1474-1480.
[14] 中华医学会检验医学分会临床微生物学组. MALDI-TOF MS鉴定病原微生物临床应用专家共识[J]. 中华检验医学杂志, 2024, 47(9): 1013-1026.
[15] 杨雪迎, 赵振波, 刘雨婷, 等. 基于宏基因组测序的间质性肺病患者下呼吸道微生物组特征及与疾病进展相关性分析[J]. 中国病原生物学杂志, 2025, 20(10): 1279-1284.
[16] 朱常军, 杜兴冉, 吕敏捷, 等. 支气管肺泡灌洗液高通量测序技术在成人肺部感染中的应用价值[J]. 国际呼吸杂志, 2022, 42(15): 1148-1157.
[17] 况红艳, 蒋亚芬, 赵志刚, 等. 支气管肺泡灌洗液宏基因组二代测序对肺结核的诊断价值[J]. 中华实用诊断与治疗杂志, 2024, 38(4): 402-406.
[18] 况红艳, 蒋亚芬, 赵志刚, 等. 宏基因组二代测序在免疫功能低下宿主肺炎诊断中的价值[J]. 中华实用诊断与治疗杂志, 2024, 38(3): 275-279.
[19] Xu, Y., Wu, W., Dong, D., Liu, N., Liu, J., Qi, B., et al. (2026) The Value of Metagenomic Next-Generation Sequencing in Lower Respiratory Tract Infections among Critically Ill Patients in the ICU. Frontiers in Cellular and Infection Microbiology, 16, Article ID: 1746117. [Google Scholar] [CrossRef
[20] 陈旭, 简春利, 杨峤, 等. BALF宏基因组二代测序分析恶性肿瘤伴发肺部炎症的病原谱特征及临床意义[J]. 重庆医科大学学报, 2025, 50(6): 742-749.
[21] Takahashi, Y., Saito, A., Chiba, H., Kuronuma, K., Ikeda, K., Kobayashi, T., et al. (2018) Impaired Diversity of the Lung Microbiome Predicts Progression of Idiopathic Pulmonary Fibrosis. Respiratory Research, 19, Article No. 34. [Google Scholar] [CrossRef] [PubMed]
[22] Xu, N., Wang, L., Li, C., Ding, C., Li, C., Fan, W., et al. (2020) Microbiota Dysbiosis in Lung Cancer: Evidence of Association and Potential Mechanisms. Translational Lung Cancer Research, 9, 1554-1568. [Google Scholar] [CrossRef] [PubMed]
[23] Wang, P., Ge, C., Jing, X., Han, Q., Wang, M., Huang, M., et al. (2025) Respiratory Microbiome-Host Interaction on Lung Carcinogenesis, Immunity, and Immunotherapy. Frontiers in Immunology, 16, Article ID: 1676302. [Google Scholar] [CrossRef
[24] Mac Aogáin, M., Dicker, A.J., Mertsch, P. and Chotirmall, S.H. (2024) Infection and the Microbiome in Bronchiectasis. European Respiratory Review, 33, Article ID: 240038. [Google Scholar] [CrossRef] [PubMed]
[25] Azoicai, A., Lupu, A., Alexoae, M.M., Starcea, I.M., Mocanu, A., Lupu, V.V., et al. (2024) Lung Microbiome: New Insights into Bronchiectasis’ Outcome. Frontiers in Cellular and Infection Microbiology, 14, Article ID: 1405399. [Google Scholar] [CrossRef] [PubMed]
[26] Zhou, J., Hou, W., Zhong, H. and Liu, D. (2024) Lung Microbiota: Implications and Interactions in Chronic Pulmonary Diseases. Frontiers in Cellular and Infection Microbiology, 14, Article ID: 1401448. [Google Scholar] [CrossRef] [PubMed]
[27] Zhu, Y. and Chang, D. (2023) Interactions between the Lung Microbiome and Host Immunity in Chronic Obstructive Pulmonary Disease. Chronic Diseases and Translational Medicine, 9, 104-121. [Google Scholar] [CrossRef] [PubMed]
[28] 中华医学会呼吸病学分会. 下呼吸道感染宏基因组二代测序报告临床解读路径专家共识[J]. 中华结核和呼吸杂志, 2023, 46(4): 322-335.
[29] 中华医学会检验医学分会, 鲁辛辛, 王成彬, 等. 高通量宏基因组测序技术检测病原微生物的临床应用规范化专家共识[J]. 中华检验医学杂志, 2020, 43(12): 1181-1195.
[30] 中华医学呼吸病学分会, 曹彬, 瞿介明. 下呼吸道感染宏基因组二代测序报告临床解读路径专家共识[J]. 中华结核和呼吸杂志, 2023, 46(4): 322-335.